News

News and Announcements

March 29, 2022

ClearLight Bio Exhibiting at AACR 2022, April 10-13

March 22, 2022

Dr. Sharla White Featured on Society of Toxicology Panel

March 21, 2022

ClearLight Biotechnologies, Inc., today announced that it has added a customized MuVi SPIM CS Light-Sheet Microscope from Luxendo, a Bruker company, to its portfolio of imaging solutions.

March 17, 2022

Bruker | ClearLight Webinar – Imaging Complex Structure with CLARITY and Light-Sheet Fluorescence Microscopy

March 11, 2022

Antibody Feasibility for CLARITY: What does it mean?

February 17, 2022

Dr. White Featured on Digital Pathology Place Podcast

January 26, 2022

ClearLight at Precision in Drug Discovery and Development Summit West 2022

December 9, 2021

Dr. White Featured on Her Royal Science Podcast

November 27, 2021

CLARITY Tissue Clearing Kits: Video Intro

November 15, 2021

ClearLight Bio Lab Services Now Available on Scientist.com

October 8, 2021

Dr. Sharla White Featured on People of Pathology Podcast

September 27, 2021

ClearLight Bio Exhibiting at SITC 2021, November 10-14

September 8, 2021

AACR Webinar – Enter the Microenvironment: New Opportunities in Tissue Clearing and 3D Imaging

August 23, 2021

Dr. Sharla White Featured in Life Sciences Review

August 11, 2021

Better Understanding of the Tissue Microenvironment

July 28, 2021

A CRO of a Different Breed

July 5, 2021

Get More Value from your Tissue Samples with a Retrospective Study

June 1, 2021

ClearLight will be at Precision in Drug Discovery and Preclinical Virtual Summit (East Coast) 2021

May 7, 2021

ClearLight will be at BIO Digital 2021

March 16, 2021

ClearLight Biotechnologies Announces Japanese Distributor Filgen

March 1, 2021

Implantable Device Case Study

February 2, 2021

ClearLight will be at Immuno-Oncology 360° 2021, happening February 23-26, 2021!

October 10, 2020

ClearLight Biotechnologies Announces CLARITY Tissue Clearing Kits

January 28, 2020

ClearLight Biotechnologies Announces Issuance of U.S. Patent No. 10,545,075

September 10, 2019

ClearLight Biotechnologies Signs an Exclusive License Agreement to Develop and Commercialize the CRYSTAL Technology, Invented at the University of Zurich and the University Hospital Zurich

August 13, 2019

Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues

April 11, 2019

ClearLight Biotechnologies and Researchers at the Indiana University’s Melvin and Bren Simon Cancer CenterAnnounce the publication of “Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues, “in Scientific Reports-Nature.

March 29, 2019

ClearLight Biotechnologies to Present Data on the Multi-sample automation and 3D analysis of CLARITY processed tissue

January 8, 2019

ClearLight Biotechnologies, Inc (ClearLight): Developing a Next-Generation 3D Tissue Processing Platform by Leveraging CLARITY is recognized as one of “The 20 Most Disruptive Healthcare Solution Providers 2018.”

November 13, 2018

ClearLight Biotechnologies, Inc (ClearLight) is recognized as one of the “15 Most Promising BioTech Startups of 2018”.

October 23, 2018

ClearLight Biotechnologies, Inc (ClearLight) (Formerly: ClearLight Diagnostics, LLC) Announces a Company Name Change and the Introduction of a Pilot Laboratory Service Model Based on the CLARITY Technology

September 26, 2018

ClearLight Diagnostics Announces the Appointment of Laurie Goodman, Ph.D. as Chief Executive Officer

July 27, 2018

Three-dimensional intact-tissue sequencing of single-cell transcriptional states

May 20, 2018

Hydrogel-Tissue Chemistry: Principles and Applications

May 8, 2018

ClearLight Diagnostics Announces the Appointment of Laurie Goodman, PhD as Interim Chief Executive Officer and the Close of an Additional Round of Funding

January 3, 2018

ClearLight Diagnostics to Present at the 10th Annual Biotech Showcase™

December 4, 2017

ClearLight Diagnostics to Present Data on the 3D Imaging of Biomarkers in Core Needle Biopsies of Breast Cancer Patients

November 7, 2017

ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights for 3D Visualization, Image Processing, and Novel CLARITY-based Tissue Clearing Instrumentation

July 19, 2017

Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and disease

May 2, 2017

ClearLight Diagnostics and Researchers at the Indiana University’s Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer

April 5, 2017

Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue

March 29, 2017

ClearLight Diagnostics to Present Data on the Multiplex 3D Imaging of the Tumor Microenvironment in a Variety of Preclinical and Clinical Cancer Models

December 6, 2016

ClearLight Diagnostics Raises $3.5M

November 8, 2016

ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights from Stanford University for SPED microscopy and RNA Interrogation Technology in CLARITY Processed Tissue Samples

October 5, 2016

ClearLight Diagnostics and the OHSU Center for Spatial Systems Biomedicine Collaborate to Define Tumor Microenvironment in Pancreatic Cancer

October 3, 2016

A Look Inside the Brain

September 15, 2016

ClearLight Diagnostics Announces the Appointment of Laurie Goodman, PhD to its Executive Staff

February 12, 2016

Multiplexed Intact-Tissue Transcriptional Analysis at Cellular Resolution

October 1, 2015

ClearLight Diagnostics Licenses Intellectual Property Rights from Stanford University for Tissue Processing and Imaging Technologies CLARITY and COLM

May 1, 2015

ClearLight Diagnostics Announces the Appointment of Sarah McCurdy, MBA as its Chief Executive Officer

May 17, 2013

Structural and molecular interrogation of intact biological systems

April 30, 2013

Nature Posts CLARITY Video

February 3, 2013

CLARITY for mapping the nervous system